Matching articles for "Azmiro"
Issue 1724 · March 17, 2025 Free
In Brief: Azmiro — A Single-Dose Injectable Formulation of Testosterone Cypionate

The FDA has approved Azmiro (Azurity), the first injectable formulation of testosterone cypionate to become available in single-dose vials and prefilled syringes for treatment of males with conditions…

Med Lett Drugs Ther. 2025 Mar 17; 67(1724):44-5 doi:10.58347/tml.2025.1724b
The FDA has approved Azmiro (Azurity), the first injectable formulation of testosterone cypionate to become available in single-dose vials and prefilled syringes for treatment of males with conditions associated with a deficiency or absence of endogenous testosterone. Injectable testosterone cypionate has been available in multidose vials ( Depo-Testosterone , and generics) for many years. Testosterone enanthate (Xyosted) is available in prefilled autoinjectors for use in adult men. No testosterone products are approved for treatment of low testosterone levels due solely to aging. All testosterone products are classified as schedule III controlled substances.